Medical Health & Life Science Research News

Research analyzes the giants dominating the global diabetes pen market

The Global Diabetes Pen Market accounted to USD 5.9 billion in 2016 growing at a CAGR of 7.5% during the forecast period of 2017 to 2024.

The upcoming Diabetes Pen Market Make an Inquiry about this news report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

Get a Free Sample Report @…abetes-pen-market Make an Inquiry about this news

New research report of Global Diabetes Pen Market Analysis with Top Comapnies as recent  as 2017 and forecasts up to 2024 that helps you track the unprecedented growth seen in Medical Device Industry giving you an edge to not just compete but to outmatch the competition.

TOP Competitors of Market:

  • AstraZeneca, BD,
  • Eli Lilly and Company,
  • Biocon,
  • Sanofi,
  • Jiangsu Delfu medical device Co.,Ltd.,
  • Owen Mumford Ltd.,
  • Smiths Group plc.,
  • P&B Pharmaceuticals Ltd.,
  • NIPRO Medical Corporation,
  • Novo Nordisk A/S,
  • InjexUK,
  • Bristol-Myers Squibb Company,
  • F. Hoffmann-La Roche Ltd.,
  • Copernicus,
  • Ypsomed and HTL-STREFA S.A.
  • among others.

Ask for  Detail TOC @…abetes-pen-market Make an Inquiry about this news

Competitive Landscape: 

The global diabetes pen market is highly fragmented and is based on new product launches and clinical results of products.

Hence the major players have used various strategies such as new product launches, clinical trials, market initiatives, high expense on research and development, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of diabetes pen market for global, Europe, North America, Asia Pacific and South America.

Speak to Our Expert @…abetes-pen-market Make an Inquiry about this news

Major Market Drivers:

  • Growth in prevalence of diabetes cases in varied age group.
  • Growth in product launches
  • Promising regulations.
  • Growth in awareness amongst people.
  • Increased R&D investments.
  • Safety issues related to reusable injection pen restrain the market.

Market Segmentation: 

The global diabetes pen market is segmented by indication into type I diabetes and type II diabetes.

On the basis of product type:- Insulin pens and insulin pen needles.

On the basis of types:- Disposable and reusable.

On the basis of therapies:- Insulin, glucagon-like peptide-1 and growth hormones.

By end users:- Hospitals, clinics and home care settings.

On the basis of geography:- North America & South America, Europe, Asia-Pacific, and Middle East & Africa. U.S., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa, and Brazil among others.

In 2017, North America is expected to dominate the market.

Browse full report @…betes-pen-market/ Make an Inquiry about this news

News From

Data Bridge Market ResearchData Bridge Market Research
Category: Market Research Publishers and RetailersCompany about: Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data bridge is an aftermath of sheer wi ...
This email address is being protected from spambots. You need JavaScript enabled to view it.

For more information:

Make an Inquiry about this report HERE!